Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
European Journal of Immunology
|
October 1, 1998
Induction and functional characterization of beta2-microglobulin (beta2-mu)-free HLA class I heavy chains expressed by beta2-mu-deficient human FO-1 melanoma cells
Z Wang, F Arienti, G Parmiani, et al.
The International Journal of Biological Markers
|
July 1, 1992
CEA and NCA expressed by colon carcinoma cells affect their interaction with and lysability by activated lymphocytes
L Rivoltini, G Cattoretti, F Arienti, et al.
European Journal of Immunology
|
October 1, 1995
A B7-1-transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and allogeneic lymphocytes
J Sulé-Suso, F Arienti, C Melani, et al.
Methods in Molecular Medicine
|
February 11, 2012
Gene therapy in melanoma
G Parmiani, F Arienti, C Melani, et al.
The Journal of Clinical Investigation
|
June 24, 1998
beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma
D J Hicklin, Z Wang, F Arienti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Neuropsychological and neurophysiological assessment of the central effects of interleukin-2 administration
A Caraceni, C Martini, F Belli, et al.
International Journal of Cancer
|
March 12, 1991
The high lysability by LAK cells of colon-carcinoma cells resistant to doxorubicin is associated with a high expression of ICAM-1, LFA-3, NCA and a less-differentiated phenotype
L Rivoltini, G Cattoretti, F Arienti, et al.
Blood
|
March 1, 1993
Human CD4 lymphocytes specifically recognize a peptide representing the fusion region of the hybrid protein pml/RAR alpha present in acute promyelocytic leukemia cells
C Gambacorti-Passerini, F Grignani, F Arienti, et al.
Human Gene Therapy
|
November 1, 1995
A human melanoma cell line transduced with an interleukin-4 gene by a retroviral vector releases biologically active IL-4 and maintains the original tumor antigenic phenotype
C Melani, J Sulé-Suso, F Arienti, et al.
The International Journal of Biological Markers
|
January 1, 1993
Chronic effects of subcutaneous interleukin-2 therapy on soluble interleukin-2 receptors in advanced small cell lung cancer
S Viviani, P M Salvini, P Bidoli, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
European Journal of Immunology
|
October 1, 1998
Induction and functional characterization of beta2-microglobulin (beta2-mu)-free HLA class I heavy chains expressed by beta2-mu-deficient human FO-1 melanoma cells
Z Wang, F Arienti, G Parmiani, et al.
The International Journal of Biological Markers
|
July 1, 1992
CEA and NCA expressed by colon carcinoma cells affect their interaction with and lysability by activated lymphocytes
L Rivoltini, G Cattoretti, F Arienti, et al.
European Journal of Immunology
|
October 1, 1995
A B7-1-transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and allogeneic lymphocytes
J Sulé-Suso, F Arienti, C Melani, et al.
Methods in Molecular Medicine
|
February 11, 2012
Gene therapy in melanoma
G Parmiani, F Arienti, C Melani, et al.
The Journal of Clinical Investigation
|
June 24, 1998
beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma
D J Hicklin, Z Wang, F Arienti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Neuropsychological and neurophysiological assessment of the central effects of interleukin-2 administration
A Caraceni, C Martini, F Belli, et al.
International Journal of Cancer
|
March 12, 1991
The high lysability by LAK cells of colon-carcinoma cells resistant to doxorubicin is associated with a high expression of ICAM-1, LFA-3, NCA and a less-differentiated phenotype
L Rivoltini, G Cattoretti, F Arienti, et al.
Blood
|
March 1, 1993
Human CD4 lymphocytes specifically recognize a peptide representing the fusion region of the hybrid protein pml/RAR alpha present in acute promyelocytic leukemia cells
C Gambacorti-Passerini, F Grignani, F Arienti, et al.
Human Gene Therapy
|
November 1, 1995
A human melanoma cell line transduced with an interleukin-4 gene by a retroviral vector releases biologically active IL-4 and maintains the original tumor antigenic phenotype
C Melani, J Sulé-Suso, F Arienti, et al.
The International Journal of Biological Markers
|
January 1, 1993
Chronic effects of subcutaneous interleukin-2 therapy on soluble interleukin-2 receptors in advanced small cell lung cancer
S Viviani, P M Salvini, P Bidoli, et al.
Page
of 4